CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-18 | El-Hibri Fuad Chairman | Sale | −15,614 | $63.90 | $998K | 1,479,018 |
| 2020-02-18 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −15,614 | 23,318 | ||
| 2020-02-14 | El-Hibri Fuad Chairman | Option exercise | +4,386 | $25.62 | $112K | 1,483,404 |
| 2020-02-14 | El-Hibri Fuad Chairman | Sale | −4,386 | $63.90 | $280K | 1,479,018 |
| 2020-02-14 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −4,386 | 38,932 | ||
| 2020-02-12 | El-Hibri Fuad Chairman | Option exercise | +13,720 | $25.62 | $352K | 1,492,738 |
| 2020-02-12 | El-Hibri Fuad Chairman | Sale | −13,720 | $62.90 | $863K | 1,479,018 |
| 2020-02-12 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −13,720 | 43,318 | ||
| 2020-02-11 | El-Hibri Fuad Chairman | Option exercise | +6,280 | $25.62 | $161K | 1,485,298 |
| 2020-02-11 | El-Hibri Fuad Chairman | Sale | −6,280 | $62.90 | $395K | 1,479,018 |
| 2020-02-11 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −6,280 | 57,038 | ||
| 2020-02-06 | El-Hibri Fuad Chairman | Option exercise | +11,684 | $25.62 | $299K | 1,479,018 |
| 2020-02-06 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −11,684 | 63,318 | ||
| 2020-02-06 | El-Hibri Fuad Executive Chairman | Sale | −11,684 | $61.90 | $723K | 1,419,018 |
| 2020-02-05 | El-Hibri Fuad Chairman | Option exercise | +20,000 | $25.62 | $512K | 1,499,018 |
| 2020-02-05 | El-Hibri Fuad Chairman | Option exercise | +20,000 | $25.62 | $512K | 1,519,018 |
| 2020-02-05 | El-Hibri Fuad Chairman | Option exercise | +8,316 | $25.62 | $213K | 1,479,018 |
| 2020-02-05 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −20,000 | 103,318 | ||
| 2020-02-05 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −20,000 | 83,318 | ||
| 2020-02-05 | El-Hibri Fuad Chairman | Option exercise · Employee Stock Options (Right to Buy) | −8,316 | 75,002 |
Page 30 of 31 · 601 trades